Francesco Fanfani Gynecologic Oncology Dpt. Obstetrics & Gynecology Catholic University - Rome Radical trachelectomy in.

Slides:



Advertisements
Similar presentations
Cervical Cancer.
Advertisements

In the name of God Isfahan medical school Shahnaz Aram MD.
Breast Cancer in Pregnancy
Incorporating Cesium-131 Interstitial Implants into Daily Clinical Practice: How to Make Radiation appear exactly where you want. Jonathan Feddock, MD.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Cara Pessel, MD et al American Journal of Obstetrics and Gynecology 2013.
Cervical Cancer: Prevention and Treatment
Cervical cancer Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Case Presentations: Pre-Invasive Cervical Neoplasia
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Hot topics in breast radiotherapy Mark Beresford.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Fertility Sparing Surgery (FSS) in Gynecologic Oncology
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Algorithms for management of Cervical cancer Algorithms for management of cervical cancer are based on existing protocols and guidelines within the ESGO.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Fertility Sparing in Gynecological Cancers Fırat Ortaç, MD Güven Hospital Güven Hospital Department of Obstetrics and Gynecology Department of Obstetrics.
Stage II Stage II - Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall. –Stage.
Fertility Sparing in Gynecological Cancers
Conservative Surgery to Preserve Fertility in Gynaecological Cancers. Sean Kehoe Oxford Gynaecological Cancer Centre Churchill Hospital Oxford.
+ Giorgia Mangili MD Cristina Sigismondi MD IRCCS Ospedale San Raffaele, Milan Gynecology Oncology Department Prof. M.Candiani The presenter has no conflict.
Conservative Management of Borderline Ovarian Tumor Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol.
1www.zohrehyousefi.com Less Radical Surgery for Patients with Early-Stage Cervical Cancer Dr.Yousefi Professor Mashhad University of Medical Sciences.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Background Sentinel lymph node biopsy has been recently introduced in the clinical setting because it is highly accurate in predicting the lymph node status.
Less Radical Surgery for Patients with Early-Stage Cervical Cancer Dr Marie Plante NCIC CTG, Cervix Working Group GCIG meeting Belgrade, Oct 10-11, 2009.
In the name of God Isfahan medical school Shahnaz Aram MD.
Dpt. Obstetrics & Gynecology Catholic University - Rome
Endometrial Carcinoma
Failure of Treatment in Cervical Cancer Patients *Dr. Zohreh Yousefi fellow ship of gynecology oncology of Mashhad university Fatemeh Homaee, Marzieh.
Are there benefits from chemotherapy to early endometrial cancer
Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.
Ali AYHAN, MD Baskent University School of Medicine Department of Obstetrics & Gynecology Division of Gynecologic Oncology Fertility Sparing Surgery (FSS)
Histopathological evaluation of lymphatic nodules in cancer of the uterine cervix Coordinators: First Author: Asist. Univ. Dr. Chira Liliana Stud. Bogdan.
Cancer Cx. Que-1 The most common gynecological malignancy in the world is – a) Vaginal Ca b) Cervical Ca c) Uterine Ca d) Ovarian Ca.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
Oncology / Dysplasia Unit Royal Women’s Hospital, Carlton, Victoria Do all patients with invasive cervical carcinoma need a radical hysterectomy? Leuven.
Cervical Cancer Xin LU OB/GYN Hospital Fudan University.
INCOMPETENT CERVIX Definition: painless dilatation of the cervix without contractions.
THE OUTBACK TRIAL A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared.
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma JIN Chen, YAO Lie, LONG.
Annals of Oncology 24: 2206–2223, 2013 R3 조영학
Optimal Approaches for Patients With Recurrent or Metastatic Cervical Cancer This program is supported by an educational grant from AstraZeneca.
HE-4 TRIAL Prospective phase II trial on the prognostic and predictive value of HE-4 regression during neoadjuvant chemotherapy for advanced ovarian, Fallopian.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
Synchronous Ovarian and Endometrial Carcinomas; An Unusual Outcome of First Trimester Ultrasound Scanning. Karl McPherson, Rhona Lindsay, Jaimie Thiesen-Nash,
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
Management of early stage cervical cancer
ELIGIBILITY CRITERIA- Summarised
Trreatment of Preinvasive Lesions
2nd trimester Miscarraige
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
Surgical Treatment in Locally Advanced Prostate Cancer
Ignace Vergote, MD PhD FACS Voorzitter Leuvens Kanker Instituut (LKI)
Cervical Cancer Tiffany Smith HCP 102.
The POSITIVE study A large international research effort coordinated by International Breast Cancer Study Group (IBCSG) worldwide ALLIANCE for Clinical.
Myomectomy over forties
Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven
Uterine cancer Uterine mesenchymal neoplasms
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
Neoadjuvant Adjuvant Curative Palliative
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Presentation transcript:

Francesco Fanfani Gynecologic Oncology Dpt. Obstetrics & Gynecology Catholic University - Rome Radical trachelectomy in patients who wish to conceive

Actual fertility-sparing treatments at Catholic University – Rome, Italy Operative ISC+HT Conization plus LPS LFN ± CT Borderline tumors Early stage Borderline tumors Early stage

The 2nd most frequent cancer in European young women IARC, EU, female (age 15–49) New cancers: 106,906 28% of all and 39% of stage I are <40 years old Definite trend toward deferral of childbearing into the late 30s and early 40s has been documented. A higher and higher proportion of patients will be diagnosed with CC before having started or completed their childbearing program

FERTILITY PRESERVATION APPROACHES: WHICH? Radical trachelectomy Vaginal (RVT) Abdominal (RAT) Laparoscopic RVT Laparoscopic RAT Neo-adjuvant CT + RT Neoadjuvant CT + conization

General inclusion criteria: Detailed informed consent Age < 40 years Strong desire to retain fertility No clinical evidence of impaired fertility Stage IA1 with LVSI – IB1 No small-cell neuroendocrine carcinoma Tumor volume < 2 cm (Colposcopy/US/MRI) Stroma infiltration < 50% No pelvic/aortic nodes (CT or PET-CT)

Intraoperative assessment: No extra-uterine spread No lymph node or SLNs metastasis Adequate margin of healty stroma assured Frozen section

RADICAL TRACHELECTOMY: A LITTLE HISTORY RADICAL TRACHELECTOMY: A LITTLE HISTORY First description of “colpohisterectomia largita subfundica” for microcarcinoma and in situ cervical carcinoma Aburel, ’32,’73,’81 Development of Radical Vaginal Trachelectomy (RVT) Dargent, ‘94 Radical Abdominal Trachelectomy (RAT) is popularized Smith, ’97 RAT with ligation of the uterine arteries Rodriguez, ’01 Total laparoscopic radical trachelectomy proposed as an alternative approach Cibula, ‘05

Rob L. et al Lancet Oncol 2010

Fertility outcome in early CC pts undergoing RVT undergoing RVT Only 40% of women administered fertility preservation procedure attempts to conceive Need to psycho-physically recover from surgery No partner at time of study Other not addressed reasons THE ABANDONMENT OF FERTILITY IS WORTH FURTHER CAREFUL INVESTIGATION

In 25-30% of cases attempting to conceive infertility is found Infertility status was already known prior to fertility preserving surgery In case of post-surgical infertility: 75% related to the “cervical factor”: absence of cervical mucus cervical stenosis :15% 12% related to anovulation 12% idiopathic (subclinical salpingitis?) Patients should be evaluated for their fertility status before surgery Should infertility be a contra-indication to fertility preserving surgery? - Cases of spontaneous pregnancy -Role of ART Fertility outcome in early CC pts undergoing RVT undergoing RVT

Trachelectomy ( 700 cases since1994) Obstetrical results Oncological results Obstetrical results Safety Early miscarriages: 20% Tardive miscarriages: 10% pPROM + Pre-term deliveries: 30% Gien et al, Gyn Onc 2010

Maneo 16 pts FIGO stage IA2-IB1. Landoni Follow up69 months Relapses0 Obstetric follow up 9/16 pts planned to conceive Miscarriage1 spontaneous (first trimester) Spontaneous deliveries at term 2 (1 pt) Casarean sections7 Prophylactic cerclage 7 (first trimester) 11 pts FIGO stage IA2-IB1. Follow up20 months Relapses0 Obstetric follow up 3/6 pts planned to conceive Miscarriage0 Spontaneous deliveries at term 3 Casarean sections 0 Prophylactic cerclage 0

This was a prospective single-institution study, including consecutive patients with early-stage CC (FIGO stages IA2– IB1).

Inclusion Criteria 1.Tumoral volume ≤ 20 mm 2.No previous CT and/or RT. 3.No preoperative suspicious lymph nodes. 4. Age ≤ 45 years. 5. FIGO stage IA2-IB1.

Follow up20 months (12-111) Recurrence0 Follow up5/13 pts (40%) tried to conceive Miscarriage/CT0 Deliveries (no preterm)2 (40%) [2 pts] FIVET3 (60%), no pregnancy Cervical cerclage0

37 IB1 CC submitted to simple conization + pelvic LFN Median tumor 11.7 mm (8-25) Follow up 66 months (6-168) 1 (2.7%) pelvic lymph node recurrence 22 pregnancies, in 17 pts (45.9%) and 14 live babies 2 (5.4%) preterm deliveries (27-32 w) 3 (8.1%) first trimester miscarriages, 1 (2.7%) second trimester, 1 (2.7%) GEU. 5 (13.5%) wanted hysterectomy (after 3-12 ys); 1 residual microinvasive adenocarcinoma was found

UCSC algorithm fo early stage CC desiring FS surgery LPS removal of pelvic lymphatic center frozen section -ve+ve RHCold knife conization -ve margin/nodes+ve nodes+ve margin -ve nodes FU Adjuvant Therapy

UCSC ongoing trials  Chemo-conization for FIGO stage IB1-IIA1 larger than 2 cm.  SLN in FIGO stage IB1-IIA1 smaller or equal to 2 cm.  Prospective avaluation of QoL after cone biopsy with respect to trachelectomy

Take home messages Early stage cervical women should be counseled about the possibilities of a fertility-sparing management. Early stage cervical women should be counseled about the possibilities of a fertility-sparing management. Strict inclusion criteria have to be applied. Strict inclusion criteria have to be applied. Management of young women with early gynecologic cancer should therefore be individualized with the risk of conservative therapy balanced against the dangers and advantages of more radical therapy. Management of young women with early gynecologic cancer should therefore be individualized with the risk of conservative therapy balanced against the dangers and advantages of more radical therapy. The field of oncofertility requires therefore a multidisciplinary approach which should include a specialized team. The field of oncofertility requires therefore a multidisciplinary approach which should include a specialized team.

Thank you for your attention